TORONTO--Base4 Bioinfor-matics said it is dropping the word bioinformatics from its name to reflect its significantly expanded strategy, beyond providing bioinformatics services. The company's broader mission includes selling its knowledge-management enterprise software package for pharmaceutical research and development.
Martin Sumner-Smith, Base4's president and CEO, said the company got its start "by offering products and services to manage the flood of biological information coming from gene analysis." Now, he said, the company serves general information needs of pharmaceutical discovery and development. "Base4 is now a general pharmaceutical informatics company."
Base4 claimed that there are nearly 1,000 users of its flagship product PharMatrix.